We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

31 hedge funds and large institutions have $10.2M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

7% more funds holding

Funds holding: 2931 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less capital invested

Capital invested by funds: $11.5M → $10.2M (-$1.33M)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
5
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TLOG Hedge Fund Activity: Q4 2015 in Review

31 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q4 2015, worth a combined $10.2M — down 12% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TLOG positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $46.9K. The largest seller was First Eagle Investment Management, cutting an estimated $221K.

  • 31 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q4 2015, up from 29 in Q3 2015.
  • Funds reported $10.2M of TetraLogic Pharmaceuticals Corporation stock for Q4 2015, down 12% quarter-over-quarter.
  • 5 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q4 2015 and 3 closed out, a net change of +2 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q4 2015 was Renaissance Technologies, an estimated $46.9K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q4 2015 was First Eagle Investment Management, an estimated $221K sold.

Based on aggregated 13F filings for Q4 2015.